Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers
Medicinal Research Reviews · 2023-05 · 43 (3) · 464-569
DOI: 10.1002/med.21931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 04.12.2022. Verfasst von Hassan Nasrollahpour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanostructures, Biosensing Techniques. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 435 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Breast cancer is categorized as the most widespread cancer type among women globally. On‐time diagnosis can decrease the mortality rate by making the right decision in the therapy procedure. These features lead to a reduction in medication time and socioeconomic burden. The current review article provides a comprehensive assessment for breast cancer diagnosis using nanomaterials and related technologies. Growing use of the nano/biotechnology domain in terms of electrochemical nanobiosensor designing was discussed in detail. In this regard, recent advances in nanomaterial applied for amplified biosensing methodologies were assessed for breast cancer diagnosis by focusing on the advantages and disadvantages of these approaches. We also monitored designing methods, advantages, and the necessity of suitable (nano) materials from a statistical standpoint. The main objective of this review is to classify the applicable biosensors based on breast cancer biomarkers. With numerous nano‐sized platforms published for breast cancer diagnosis, this review tried to collect the most suitable methodologies for detecting biomarkers and certain breast cancer cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Applied Cellular Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) and Department of Electronic and Electrical Engineering, University of Bath, Bath, UK.
- Koç University Translational Medicine Research Center (KUTTAM) Rumeli Feneri, Sarıyer, Istanbul, Turkey.
ORCID-Profile: Balal Khalilzadeh, Reza Rahbarghazi
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Nasrollahpour, H., Khalilzadeh, B., Hasanzadeh, M., Rahbarghazi, R., Estrela, P., Naseri, A., Tasoglu, S., & Sillanpää, M. (2023). Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers. Medicinal Research Reviews, 43(3), 464-569. https://doi.org/10.1002/med.21931
Vancouver
Nasrollahpour H, Khalilzadeh B, Hasanzadeh M, Rahbarghazi R, Estrela P, Naseri A, et al. Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers. Medicinal Research Reviews. 2023;43(3):464-569. doi:10.1002/med.21931
BibTeX
@article{Nasrollahpour2023,
author = {Nasrollahpour, Hassan and Khalilzadeh, Balal and Hasanzadeh, Mohammad and Rahbarghazi, Reza and Estrela, Pedro and Naseri, Abdolhossein and Tasoglu, Savas and Sillanpää, Mika},
title = {Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {3},
pages = {464--569},
doi = {10.1002/med.21931}
}
EUVIMED